Organ Chips/Life Science Equipment/Biological Reagents

Organ chip full-link product layout

Organs-on-Chips Product Series

Organs-on-Chips Product Series

Render the context of life through micro modeling

Life Science Device Series

Life Science Device Series

Unravel the mysteries of life through Lab-on-a-chip

Biomodels and Reagents Series

Biomodels and Reagents Series

Ensure precise, stable and refined experiments

Solutions

All-Inclusive Organ-On-A-Chip Solutions Provider

Picture Name
Picture Name
Picture Name
Picture Name

In terms of drug sensitivity tests, AVATARGET has established a highly biomimetic simulation of the human body using the organoid model+microenvironment with OoCs, and constructed an ideal prediction model for assessing the effectiveness of clinical treatment, which improves the efficiency and effectiveness of treatments.

In terms of novel drug discovery, AVATARGET has successfully developed solutions for drug efficacy and safety evaluation, including cardiac efficacy/toxicological models, hepatotoxicological models, and skin models, applicable to a variety of drug R&D scenarios, including early discovery of new drugs, lead optimization, preclinical evaluation, clinical research, drug repurposing, and drug combination studies.

AVATARGET Biotechnology specializes in the innovative R&D of human OoCs and supporting life science devices. In the field of R&D of cosmetics, with skin OoC technology as the core, we have constructed mature skin-related models, including the 3D melanin-containing epidermal model, 3D epidermal model, and 3D full-thickness skin model, and developed solutions to the efficacy and safety evaluation of cosmetics, covering the testing for skin-whitening efficacy, anti-aging efficacy, moisturizing effect, irritation, and phototoxicity.

In the field of basic scientific research, AVATARGET has launched the melanin-containing epidermal model, cardiac model, other OoC models, and chip customization service.

News

Learn more about AVATARGET

Corporate Briefs

Events Pulse

Industry Insights

Chip Roundup